Safety assessment of probiotics for human use

References

• Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria 2001; 2009 http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf
   Google Scholar
• Cannon JP, Lee TA, Bolanos JT, Danziger LH. Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis 2005; 24:125 - 126
   Web of Science ®Google Scholar
• Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005; 115:178 - 181
   PubMed Web of Science ®Google Scholar
• Salminen MK, Rautelin H, Tynkkynen S, Poussa T, Saxelin M, Valtonen V, et al. Lactobacillus bacteremia, species identification and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis 2006; 42:35 - 44
   Web of Science ®Google Scholar
• Bernardeau M, Guguen M, Vernoux JP. Beneficial lactobacilli in food and feed: long-term use, biodiversity and proposals for specific and realistic safety assessments. FEMS Microbiol Rev 2006; 30:487 - 513
   PubMed Web of Science ®Google Scholar
• Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371:651 - 659
   PubMed Web of Science ®Google Scholar
• Hennequin C, Kauffmann-Lacroix C, Jobert A, Viard JP, Ricour C, Jacquemin JL, et al. Possible role of catheters in Saccharomyces boulardii fungemia. Eur J Clin Microbiol Infect Dis 2000; 19:16 - 20
   PubMed Web of Science ®Google Scholar
• Rautio M, Jousimies-Somer H, Kauma H, Pietarinen I, Saxelin M, Tynkkynen S, et al. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 1999; 28:1159 - 1160
   PubMed Web of Science ®Google Scholar
• Mackay AD, Taylor MB, Kibbler CC, Hamilton-Miller JM. Lactobacillus endocarditis caused by a probiotic organism. Clin Microbiol Infect 1999; 5:290 - 292
   PubMedGoogle Scholar
• Spinosa MR, Braccini T, Ricca E, De Felice M, Morelli L, Pozzi G, et al. On the fate of ingested Bacillus spores. Res Microbiol 2000; 151:361 - 368
   PubMed Web of Science ®Google Scholar
• Oggioni MR, Pozzi G, Valensin PE, Galieni P, Bigazzi C. Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis. J Clin Microbiol 1998; 36:325 - 326
   PubMed Web of Science ®Google Scholar
• Kunz AN, Noel JM, Fairchok MP. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr 2004; 38:457 - 458
   PubMed Web of Science ®Google Scholar
• Boyle RJ, Robins-Browne RM, Tang ML. Probiotic use in clinical practice: what are the risks?. Am J Clin Nutr 2006; 83:1256 - 1264
   PubMed Web of Science ®Google Scholar
• Vesterlund S, Vankerckhoven V, Saxelin M, Goossens H, Salminen S, Ouwehand AC. Safety assessment of Lactobacillus strains: presence of putative risk factors in faecal, blood and probiotic isolates. Int J Food Microbiol 2007; 116:325 - 331
   PubMed Web of Science ®Google Scholar
• Borriello SP, Hammes WP, Holzapfel W, Marteau P, Schrezenmeir J, Vaara M, et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003; 36:775 - 780
   PubMed Web of Science ®Google Scholar
• Salminen MK, Tynkkynen S, Rautelin H, Saxelin M, Vaara M, Ruutu P, et al. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 2002; 35:1155 - 1160
   PubMed Web of Science ®Google Scholar
• Bernardeau M, Vernoux JP, Henri-Dubernet S, Gueguen M. Safety assessment of dairy microorganisms: the Lactobacillus genus. Int J Food Microbiol 2008; 126:278 - 285
   PubMed Web of Science ®Google Scholar
• Snydman DR. The safety of probiotics. Clin Infect Dis 2008; 46:104 - 111
   PubMed Web of Science ®Google Scholar
• O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006; 7:688 - 693
   PubMed Web of Science ®Google Scholar
• Gill HS, Rutherfurd KJ, Cross ML. Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J Clin Immunol 2001; 21:264 - 271
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Rath E, Hölzlwimmer G, Quintanilla-Martinez L, Loach D, et al. Lactobacillus reuteri 100-23 transiently activates intestinal epithelial cells of mice that have a complex microbiota during early stages of colonization. J Nutr 2008; 138:1684 - 1691
   PubMed Web of Science ®Google Scholar
• Mater DD, Langella P, Corthier G, Flores MJ. A probiotic Lactobacillus strain can acquire vancomycin resistance during digestive transit in mice. J Mol Microbiol Biotechnol 2008; 14:123 - 127
   PubMed Web of Science ®Google Scholar
• Kruis W, Fric P, Pokrotnieks J, Lukás M, Fixa B, Kascák M, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004; 53:1617 - 1623
   PubMed Web of Science ®Google Scholar
• Gionchetti P, Rizzello F, Morselli C, Poggioli G, Tambasco R, Calabrese C, et al. High-dose probiotics for the treatment of active pouchitis. Dis Colon Rectum 2007; 50:2075 - 2082
   PubMed Web of Science ®Google Scholar
• Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361:1869 - 1871
   PubMed Web of Science ®Google Scholar
• Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGFβ-bearing regulatory cells. J Immunol 2005; 174:3237 - 3246
   PubMed Web of Science ®Google Scholar
• Clark JA, Coopersmith CM. Intestinal crosstalk: a new paradigm for understanding the gut as the “motor” of critical illness. Shock 2007; 28:384 - 393
   PubMed Web of Science ®Google Scholar
• Alverdy JC, Laughlin RS, Wu L. Influence of the critically ill state on host-pathogen interactions within the intestine: gut-derived sepsis redefined. Crit Care Med 2003; 31:598 - 607
   PubMed Web of Science ®Google Scholar
• Liévin V, Peiffer I, Hudault S, Rochat F, Brassart D, Neeser JR, et al. Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 2000; 47:646 - 652
   PubMed Web of Science ®Google Scholar
• Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003; 52:988 - 997
   PubMed Web of Science ®Google Scholar
• Sherman PM, Johnson-Henry KC, Yeung HP, Ngo PS, Goulet J, Tompkins TA. Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect Immun 2005; 73:5183 - 5188
   PubMed Web of Science ®Google Scholar
• Yan F, Polk DB. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 2002; 277:50959 - 50965
   PubMed Web of Science ®Google Scholar
• Yan F, Cao H, Cover TL, Whitehead R, Washington MK, Polk DB. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007; 132:562 - 575
   PubMed Web of Science ®Google Scholar
• Petrof EO, Kojima K, Ropeleski MJ, Musch MW, Tao Y, De Simone C, et al. Probiotics inhibit nuclear factor-κB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 2004; 127:1474 - 1487
   PubMed Web of Science ®Google Scholar
• Czerucka D, Dahan S, Mograbi B, Rossi B, Rampal P. Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect Immun 2000; 68:5998 - 6004
   PubMed Web of Science ®Google Scholar
• Hart AL, Lammers K, Brigidi P, Vitali B, Rizzello F, Gionchetti P, et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004; 53:1602 - 1609
   PubMed Web of Science ®Google Scholar
• Galdeano CM, de Moreno de LeBlanc A, Vinderola G, Bonet ME, Perdigon G. Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin Vaccine Immunol 2007; 14:485 - 492
   PubMed Web of Science ®Google Scholar
• Sugawara G, Nagino M, Nishio H, Ebata T, Takagi K, Asahara T, et al. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg 2006; 244:706 - 714
   PubMed Web of Science ®Google Scholar
• Gollin G, Marks C, Marks WH. Intestinal fatty acid binding protein in serum and urine reflects early ischemic injury to the small bowel. Surgery 1993; 113:545 - 551
   PubMed Web of Science ®Google Scholar
• Besselink MG, van Santvoort HC, Renooij W, de Smet MB, Boermeester MA, Fischer K, et al. Intestinal Barrier Dysfunction in a Randomized Trial of a Specific Probiotic Composition in Acute Pancreatitis. Ann Surg 2009; 250:712 - 719
   PubMed Web of Science ®Google Scholar
• Lutgendorff F, Nijmeijer RM, Sandström PA, Trulsson LM, Magnusson KE, Timmerman HM, et al. Probiotics prevent intestinal barrier dysfunction in acute pancreatitis in rats via induction of ileal mucosal glutathione biosynthesis. PLoS ONE 2009; 4:4512
   PubMed Web of Science ®Google Scholar
• Lutgendorff F, Trulsson LM, van Minnen LP, Rijkers GT, Timmerman HM, Franzén LE, et al. Probiotics enhance pancreatic glutathione biosynthesis and reduce oxidative stress in experimental acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2008; 295:1111 - 1121
   PubMed Web of Science ®Google Scholar
• Ammori BJ. Role of the gut in the course of severe acute pancreatitis. Pancreas 2003; 26:122 - 129
   PubMed Web of Science ®Google Scholar
• Siriwardena AK, Mason JM, Balachandra S, Bagul A, Galloway S, Formela L, et al. Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis. Gut 2007; 56:1439 - 1444
   PubMed Web of Science ®Google Scholar
• Voltan S, Martines D, Elli M, Brun P, Longo S, Porzionato A, et al. Lactobacillus crispatus M247-derived H2O2 acts as a signal transducing molecule activating peroxisome proliferator activated receptor-γ in the intestinal mucosa. Gastroenterology 2008; 135:1216 - 1227
   PubMed Web of Science ®Google Scholar
• Abdelrahman M, Sivarajah A, Thiemermann C. Beneficial effects of PPAR-γ ligands in ischemia-reperfusion injury, inflammation and shock. Cardiovasc Res 2005; 65:772 - 781
   PubMed Web of Science ®Google Scholar
• The use of probiotics for patients in hospitals. A benefit and risk assessment. Opinion of the Steering Committee of the Norwegian Scientific Committee for Food Safety 2009; 2009 http://www.vkm.no/dav/009488e0b8.pdf
   Google Scholar
• Doherty G, Bennett G, Patil S, Cheifetz A, Moss AC. Interventions for prevention of post-operative recurrence of Crohn's disease. Cochrane Database Syst Rev 2009; 6873
   Google Scholar
• Rolfe VE, Fortun PJ, Hawkey CJ, Bath-Hextall F. Probiotics for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2006; 4826
   Google Scholar
• Butterworth AD, Thomas AG, Akobeng AK. Probiotics for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2008; 6634
   Google Scholar
• Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double blind, placebo-controlled trial. Gastroenterology 2000; 119:305 - 309
   PubMed Web of Science ®Google Scholar
• Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, Talbot IC, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004; 53:108 - 114
   PubMed Web of Science ®Google Scholar
• Shen B, Brzezinski A, Fazio VW, Remzi FH, Achkar JP, Bennett AE, et al. Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice. Aliment Pharmacol Ther 2005; 22:721 - 728
   PubMed Web of Science ®Google Scholar
• Mallon P, McKay D, Kirk S, Gardiner K. Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2007; 5573
   Google Scholar
• Tsuda Y, Yoshimatsu Y, Aoki H, Nakamura K, Irie M, Fukuda K, et al. Clinical effectiveness of probiotics therapy (BIO-THREE) in patients with ulcerative colitis refractory to conventional therapy. Scand J Gastroenterol 2007; 42:1306 - 1311
   PubMed Web of Science ®Google Scholar
• Huynh HQ, deBruyn J, Guan L, Diaz H, Li M, Girgis S, et al. Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study. Inflamm Bowel Dis 2009; 15:760 - 768
   PubMed Web of Science ®Google Scholar
• Miele E, Pascarella F, Giannetti E, Quaglietta L, Baldassano RN, Staiano A. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 2009; 104:437 - 443
   PubMed Web of Science ®Google Scholar
• Sood A, Midha V, Makharia GK, Ahuja V, Singal D, Goswami P, et al. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol 2009; 7:1202 - 1209
   PubMed Web of Science ®Google Scholar
• Farina C, Arosio M, Mangia M, Moioli F. Lactobacillus casei subsp. rhamnosus sepsis in a patient with ulcerative colitis. J Clin Gastroenterol 2001; 33:251 - 252
   PubMed Web of Science ®Google Scholar
• Palmer C, Bik EM, Digiulio DB, Relman DA, Brown PO. Development of the Human Infant Intestinal Microbiota. PLoS Biol 2007; 5:177
   PubMed Web of Science ®Google Scholar
• Gewolb IH, Schwalbe RS, Taciak VL, Harrison TS, Panigrahi P. Stool microflora in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 1999; 80:167 - 173
   PubMed Web of Science ®Google Scholar
• Fanaro S, Chierici R, Guerrini P, Vigi V. Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl 2003; 91:48 - 55
   PubMedGoogle Scholar
• Meng D, Newburg DS, Young C, Baker A, Tonkonogy SL, Sartor RB, et al. Bacterial symbionts induce a FUT2-dependent fucosylated niche on colonic epithelium via ERK and JNK signaling. Am J Physiol Gastrointest Liver Physiol 2007; 293:780 - 787
   Web of Science ®Google Scholar
• Bates JM, Mittge E, Kuhlman J, Baden KN, Cheesman SE, Guillemin K. Distinct signals from the microbiota promote different aspects of zebrafish gut differentiation. Dev Biol 2006; 297:374 - 386
   PubMed Web of Science ®Google Scholar
• Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007; 119:192 - 198
   PubMed Web of Science ®Google Scholar
• Saavedra JM, Abi-Hanna A, Moore N, Yolken RH. Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety. Am J Clin Nutr 2004; 79:261 - 267
   PubMed Web of Science ®Google Scholar
• Saxelin M, Chuang NH, Chassy B, Rautelin H, Mäkelä PH, Salminen S, et al. Lactobacilli and bacteremia in Southern Finland, 1989–1992. Clin Infect Dis 1996; 22:564 - 566
   PubMed Web of Science ®Google Scholar
• Hata D, Yoshida A, Ohkubo H, Mochizuki Y, Hosoki Y, Tanaka R, et al. Meningitis caused by Bifidobacterium in an infant. Pediatr Infect Dis J 1988; 7:669 - 671
   PubMed Web of Science ®Google Scholar
• Barton LL, Rider ED, Coen RW. Bacteremic infection with Pediococcus: vancomycin-resistant opportunist. Pediatrics 2001; 107:775 - 776
   PubMed Web of Science ®Google Scholar
• Honeycutt TC, El Khashab M, Wardrop RM 3rd, McNeal-Trice K, Honeycutt AL, Christy CG, et al. Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial. Pediatr Crit Care Med 2007; 8:452 - 458
   PubMed Web of Science ®Google Scholar
• Weizman Z, Asli G, Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 2005; 115:5 - 9
   PubMed Web of Science ®Google Scholar
• Vendt N, Grünberg H, Tuure T, Malminiemi O, Wuolijoki E, Tillmann V, et al. Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: double-blind, randomized trial. J Hum Nutr Diet 2006; 19:51 - 58
   PubMed Web of Science ®Google Scholar
• Risk assessment on use of Lactobacillus rhamnosus (LGG) as an ingredient in infant formula and baby foods (II) 2007; 2009 http://www.vkm.no/dav/63bb45d3eb.pdf
   Google Scholar
• Abrahamsson TR, Jakobsson T, Böttcher MF, Fredrikson M, Jenmalm MC, Björkstén B, et al. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119:1174 - 1180
   PubMed Web of Science ®Google Scholar
• Chouraqui JP, Grathwohl D, Labaune JM, Hascoet JM, de Montgolfier I, Leclaire M, et al. Assessment of the safety, tolerance and protective effect against diarrhea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial. Am J Clin Nutr 2008; 87:1365 - 1373
   PubMed Web of Science ®Google Scholar
• Gibson RA, Barclay D, Marshall H, Moulin J, Maire JC, Makrides M. Safety of supplementing infant formula with long-chain polyunsaturated fatty acids and Bifidobacterium lactis in term infants: a randomised controlled trial. Br J Nutr 2009; 101:1706 - 1713
   PubMed Web of Science ®Google Scholar
• Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357:1076 - 1079
   PubMed Web of Science ®Google Scholar
• Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, et al. Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics 2008; 122:8 - 12
   PubMed Web of Science ®Google Scholar
• Puccio G, Cajozzo C, Meli F, Rochat F, Grathwohl D, Steenhout P. Clinical evaluation of a new starter formula for infants containing live Bifidobacterium longum BL999 and prebiotics. Nutrition 2007; 23:1 - 8
   PubMed Web of Science ®Google Scholar
• Vlieger AM, Robroch A, van Buuren S, Kiers J, Rijkers G, Benninga MA, et al. Tolerance and safety of Lactobacillus paracasei ssp. paracasei in combination with Bifidobacterium animalis ssp. lactis in a prebiotic-containing infant formula: a randomised controlled trial. Br J Nutr 2009; 102:869 - 875
   PubMed Web of Science ®Google Scholar
• JW D, K W, PN B, et al. Safety aspects of probiotic bacterial strains Lactobacillus rhamnosus HN001 and Bifidobacterium animalis ssp. lactis HN019 in human infants aged 0 to 2 years. Int Dairy J 2009; 19:149 - 154
   Web of Science ®Google Scholar
• Wickens K, Black PN, Stanley TV, Mitchell E, Fitzharris P, Tannock GW, et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2008; 122:788 - 794
   PubMed Web of Science ®Google Scholar
• Stolley H, Droese W. Lactic acid in milk formula, the influence on absorption of nutrients and the influence on the metabolism in young babies. Acta Paediatr Scand 1971; 60:367 - 368
   PubMed Web of Science ®Google Scholar
• Favier CF, Vaughan EE, De Vos WM, Akkermans AD. Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 2002; 68:219 - 226
   PubMed Web of Science ®Google Scholar
• Schultz M, Gottl C, Young RJ, Iwen P, Vanderhoof JA. Administration of oral probiotic bacteria to pregnant women causes temporary infantile colonization. J Pediatr Gastroenterol Nutr 2004; 38:293 - 297
   PubMed Web of Science ®Google Scholar
• Gueimonde M, Kalliomaki M, Isolauri E, Salminen S. Probiotic intervention in neonates—will permanent colonization ensue?. J Pediatr Gastroenterol Nutr 2006; 42:604 - 606
   PubMed Web of Science ®Google Scholar
• Strachan DP. Hay fever, hygiene and household size. Bmj 1989; 299:1259 - 1260
   PubMed Web of Science ®Google Scholar
• Kalliomaki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119:1019 - 1021
   PubMed Web of Science ®Google Scholar
• Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 2008; 121:850 - 856
   PubMed Web of Science ®Google Scholar
• Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2007; 119:184 - 191
   PubMed Web of Science ®Google Scholar
• Prescott SL, Wiltschut J, Taylor A, Westcott L, Jung W, Currie H, et al. Early markers of allergic disease in a primary prevention study using probiotics: 2.5-year follow-up phase. Allergy 2008; 63:1481 - 1490
   PubMed Web of Science ®Google Scholar
• Sakata S, Tonooka T, Ishizeki S, Takada M, Sakamoto M, Fukuyama M, et al. Culture-independent analysis of fecal microbiota in infants, with special reference to Bifidobacterium species. FEMS Microbiol Lett 2005; 243:417 - 423
   PubMed Web of Science ®Google Scholar
• Bin-Nun A, Bromiker R, Wilschanski M, Kaplan M, Rudensky B, Caplan M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005; 147:192 - 196
   PubMed Web of Science ®Google Scholar
• Lin HC, Hsu CH, Chen HL, Chung MY, Hsu JF, Lien RI, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 2008; 122:693 - 700
   PubMed Web of Science ®Google Scholar
• Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, Yeh TF, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005; 115:1 - 4
   PubMed Web of Science ®Google Scholar
• Deshpande G, Rao S, Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet 2007; 369:1614 - 1620
   PubMed Web of Science ®Google Scholar
• Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002; 82:103 - 108
   PubMedGoogle Scholar
• Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci USA 2002; 99:15451 - 15455
   PubMed Web of Science ®Google Scholar
• Wagner RD. Effects of microbiota on GI health: gnotobiotic research. Adv Exp Med Biol 2008; 635:41 - 56
   PubMed Web of Science ®Google Scholar
• Hormannsperger G, Haller D. Molecular crosstalk of probiotic bacteria with the intestinal immune system: Clinical relevance in the context of inflammatory bowel disease. Int J Med Microbiol 2009;
   PubMed Web of Science ®Google Scholar
• Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 2009; 6:306 - 314
   PubMed Web of Science ®Google Scholar
• Sonnenburg JL, Chen CT, Gordon JI. Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol 2006; 4:413
   PubMed Web of Science ®Google Scholar
• Joint FAO/WHO working group report on drafting guidelines for the evaluation of probiotics in food 2002; 2009 ftp://ftp.fao.org/es/esn/food/wgreport2.pdf
   Google Scholar
• Saarela M, Mogensen G, Fonden R, Matto J, Mattila-Sandholm T. Probiotic bacteria: safety, functional and technological properties. J Biotechnol 2000; 84:197 - 215
   PubMed Web of Science ®Google Scholar
• Vankerckhoven V, Huys G, Vancanneyt M, et al. Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE project. Trend Food Sci Tech 2008; 19:102 - 114
   Web of Science ®Google Scholar
• Huys G, Vancanneyt M, D'Haene K, Vankerckhoven V, Goossens H, Swings J. Accuracy of species identity of commercial bacterial cultures intended for probiotic or nutritional use. Res Microbiol 2006; 157:803 - 810
   PubMed Web of Science ®Google Scholar
• Masco L, Huys G, De Brandt E, Temmerman R, Swings J. Culture-dependent and culture-independent qualitative analysis of probiotic products claimed to contain bifidobacteria. Int J Food Microbiol 2005; 102:221 - 230
   PubMed Web of Science ®Google Scholar
• Temmerman R, Scheirlinck I, Huys G, Swings J. Culture-independent analysis of probiotic products by denaturing gradient gel electrophoresis. Appl Environ Microbiol 2003; 69:220 - 226
   PubMed Web of Science ®Google Scholar
• Green DH, Wakeley PR, Page A, Barnes A, Baccigalupi L, Ricca E, et al. Characterization of two Bacillus probiotics. Appl Environ Microbiol 1999; 65:4288 - 4291
   PubMed Web of Science ®Google Scholar
• Duc le H, Hong HA, Barbosa TM, Henriques AO, Cutting SM. Characterization of Bacillus probiotics available for human use. Appl Environ Microbiol 2004; 70:2161 - 2171
   PubMed Web of Science ®Google Scholar
• Mohania D, Nagpal R, Kumar M, Bhardwaj A, Yadav M, Jain S, et al. Molecular approaches for identification and characterization of lactic acid bacteria. J Dig Dis 2008; 9:190 - 198
   PubMed Web of Science ®Google Scholar
• Collado MC, Moreno Y, Cobo JM, Hernandez M. Microbiological evaluation and molecular characterization of bifidobacteria strains in commercial fermented milks. Eur Food Res Technol 2006; 222:112 - 117
   Web of Science ®Google Scholar
• Coudeyras S, Marchandin H, Fajon C, Forestier C. Taxonomic and strain-specific identification of the probiotic strain Lactobacillus rhamnosus 35 within the Lactobacillus casei group. Appl Environ Microbiol 2008; 74:2679 - 2689
   PubMed Web of Science ®Google Scholar
• Massi M, Vitali B, Federici F, Matteuzzi D, Brigidi P. Identification method based on PCR combined with automated ribotyping for tracking probiotic Lactobacillus strains colonizing the human gut and vagina. J Appl Microbiol 2004; 96:777 - 786
   PubMed Web of Science ®Google Scholar
• Naser SM, Dawyndt P, Hoste B, Gevers D, Vandemeulebroecke K, Cleenwerck I, et al. Identification of lactobacilli by pheS and rpoA gene sequence analyses. Int J Syst Evol Microbiol 2007; 57:2777 - 2789
   PubMed Web of Science ®Google Scholar
• Ventura M, van Sinderen D, Fitzgerald GF, Zink R. Insights into the tazonomy genetics and physiology of bifidobacteria. Antonia van Leeuwenhoek 2004; 86:205 - 223
   PubMed Web of Science ®Google Scholar
• Rooney AP, Price NP, Ehrhardt C, Swezey JL, Bannan JD. Phylogeny and molecular taxonomy of the Bacillus subtilis species complex and description of Bacillus subtilis subsp. inaquosorum subsp. nov. Int J Syst Evol Microbiol 2009; 59:2429 - 2436
   PubMed Web of Science ®Google Scholar
• Lee YK, Ho PS, Low CS, Arvilommi H, Salminen S. Permanent colonization by Lactobacillus casei is hindered by the low rate of cell division in mouse gut. Appl Environ Microbiol 2004; 70:670 - 674
   PubMed Web of Science ®Google Scholar
• Alander M, Satokari R, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, et al. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol 1999; 65:351 - 354
   PubMed Web of Science ®Google Scholar
• Klarin B, Johansson ML, Molin G, Larsson A, Jeppsson B. Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients: a randomised open trial. Crit Care 2005; 9:285 - 293
   PubMed Web of Science ®Google Scholar
• Sorokulova I. Preclinical testing in the development of probiotics: a regulatory perspective with Bacillus strains as an example. Clin Infect Dis 2008; 46:92 - 95
   Web of Science ®Google Scholar
• Klare I, Konstabel C, Müller-Bertling S, Reissbrodt R, Huys G, Vancanneyt M, et al. Evaluation of new broth media for microdilution antibiotic susceptibility testing of Lactobacilli, Pediococci, Lactococci and Bifidobacteria. Appl Environ Microbiol 2005; 71:8982 - 8986
   PubMed Web of Science ®Google Scholar
• Klare I, Konstabel C, Werner G, Huys G, Vankerckhoven V, Kahlmeter G, Hildebrandt B, et al. Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use. J Antimicrob Chemother 2007; 59:900 - 912
   PubMed Web of Science ®Google Scholar
• Kastner S, Perreten V, Bleuler H, Hugenschmidt G, Lacroix C, Meile L. Antibiotic susceptibility patterns and resistance genes of starter cultures and probiotic bacteria used in food. Syst Appl Microbiol 2006; 29:145 - 155
   PubMed Web of Science ®Google Scholar
• Masco L, Van Hoorde K, De Brandt E, Swings J, Huys G. Antimicrobial susceptibility of Bifidobacterium strains from humans, animals and probiotic products. J Antimicrob Chemother 2006; 58:85 - 94
   PubMed Web of Science ®Google Scholar
• Huys G, D'Haene K, Swings J. Genetic basis of tetracycline and minocycline resistance in potentially probiotic Lactobacillus plantarum strain CCUG 43738. Antimicrob Agents Chemother 2006; 50:1550 - 1551
   PubMed Web of Science ®Google Scholar
• van Hoek AHAM, Margolles A, Domig KJ, et al. Molecular assessment of erythromycin and tetracycline resistance genes in lactic acid bacteria and bifidobacteria and their relation to the phenotypic resistance. International Journal of Probiotics and Prebiotics 2008; 3:271 - 280
   Google Scholar
• Update of the criteria used in the assessment of bacterial resistance to antibiotics of human or veterinary importance 2008; 2009 http://www.efsa.europa.eu/cs/BlobServer/Guidance_of_Panel/feedap_op_ej732_tg_antimicrobial_resistance_en.pdf?ssbinary=true
   Google Scholar
• Jorgensen J. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved Guideline, M45-A Clinical and Laboratory Standards Institute 2006;
   Google Scholar
• Agency Additional Correspondence Letter GRAS Notice No. GRN 000049 2005; 2009 http://www.fda.gov/Food/FoodIngredientsPackaging/GenerallyRecognizedasSafeGRAS/GRASListings/ucm154391.htm
   Google Scholar
• Vancanneyt M, Huys G, Lefebvre K, Vankerckhoven V, Goossens H, Swings J. Intraspecific genotypic characterization of Lactobacillus rhamnosus strains intended for probiotic use and isolates of human origin. Appl Environ Microbiol 2006; 72:5376 - 5383
   PubMed Web of Science ®Google Scholar
• van de Guchte M, Penaud S, Grimaldi C, Barbe V, Bryson K, Nicolas P, et al. The complete genome sequence of Lactobacillus bulgaricus reveals extensive and ongoing reductive evolution. Proc Natl Acad Sci USA 2006; 103:9274 - 9279
   PubMed Web of Science ®Google Scholar
• Olah A, Belagyi T, Issekutz A, Gamal ME, Bengmark S. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 2002; 89:1103 - 1107
   PubMed Web of Science ®Google Scholar
• Rayes N, Seehofer D, Hansen S, Boucsein K, Müller AR, Serke S, et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 2002; 74:123 - 127
   PubMed Web of Science ®Google Scholar
• Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr 2003; 36:223 - 227
   PubMed Web of Science ®Google Scholar
• Sharieff W, Bhutta Z, Schauer C, Tomlinson G, Zlotkin S. Micronutrients (including zinc) reduce diarrhoea in children: the Pakistan Sprinkles Diarrhoea Study. Arch Dis Child 2006; 91:573 - 579
   PubMed Web of Science ®Google Scholar
• Asahara T, Takahashi M, Nomoto K, Takayama H, Onoue M, Morotomi M, et al. Assessment of safety of lactobacillus strains based on resistance to host innate defense mechanisms. Clin Diagn Lab Immunol 2003; 10:169 - 173
   PubMedGoogle Scholar
• Franz CM, Muscholl-Silberhorn AB, Yousif NM, Vancanneyt M, Swings J, Holzapfel WH. Incidence of virulence factors and antibiotic resistance among Enterococci isolated from food. Appl Environ Microbiol 2001; 67:4385 - 4389
   PubMed Web of Science ®Google Scholar
• Eaton TJ, Gasson MJ. Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. Appl Environ Microbiol 2001; 67:1628 - 1635
   PubMed Web of Science ®Google Scholar
• Ge J, Catt DM, Gregory RL. Streptococcus mutans surface α-enolase binds salivary mucin MG2 and human plasminogen. Infect Immun 2004; 72:6748 - 6752
   PubMed Web of Science ®Google Scholar
• Mack DR. D(−)-lactic acid-producing probiotics, D(−)-lactic acidosis and infants. Can J Gastroenterol 2004; 18:671 - 675
   PubMed Web of Science ®Google Scholar
• Hove H, Mortensen PB. Colonic lactate metabolism and D-lactic acidosis. Dig Dis Sci 1995; 40:320 - 330
   PubMed Web of Science ®Google Scholar
• Walter J. Ecological role of lactobacilli in the gastrointestinal tract: implications for fundamental and biomedical research. Appl Environ Microbiol 2008; 74:4985 - 4996
   PubMed Web of Science ®Google Scholar
• Bongaerts G, Bakkeren J, Severijnen R, Sperl W, Willems H, Naber T, et al. Lactobacilli and acidosis in children with short small bowel. J Pediatr Gastroenterol Nutr 2000; 30:288 - 293
   PubMed Web of Science ®Google Scholar
• Connolly E, Abrahamsson T, Bjorksten B. Safety of D(−)-lactic acid producing bacteria in the human infant. J Pediatr Gastroenterol Nutr 2005; 41:489 - 492
   PubMed Web of Science ®Google Scholar
• Uribarri J, Oh MS, Carroll HJ. D-lactic acidosis. A review of clinical presentation, biochemical features and pathophysiologic mechanisms. Medicine 1998; 77:73 - 82
   PubMed Web of Science ®Google Scholar
• Hove H. Lactate and short chain fatty acid production in the human colon: implications for D-lactic acidosis, short-bowel syndrome, antibiotic-associated diarrhoea, colonic cancer and inflammatory bowel disease. Dan Med Bull 1998; 45:15 - 33
   PubMed Web of Science ®Google Scholar
• Munakata S, Arakawa C, Kohira R, Fujita Y, Fuchigami T, Mugishima H. A case of D-lactic acid encephalopathy associated with use of probiotics. Brain Dev 2009;
   PubMed Web of Science ®Google Scholar
• Uchida H, Yamamoto H, Kisaki Y, Fujino J, Ishimaru Y, Ikeda H. D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics. J Pediatr Surg 2004; 39:634 - 636
   PubMed Web of Science ®Google Scholar
• MMWR, Leads from the MMWR. Scombroid fish poisoning—New Mexico, 1987. Jama 1988; 260:1217
   PubMedGoogle Scholar
• Straub BW, Kicherer M, Schilcher SM, Hammes WP. The formation of biogenic amines by fermentation organisms. Z Lebensm Unters Forsch 1995; 201:79 - 82
   PubMedGoogle Scholar
• Pessione E, Mazzoli R, Giuffrida MG, Lamberti C, Garcia-Moruno E, Barello C, et al. A proteomic approach to studying biogenic amine producing lactic acid bacteria. Proteomics 2005; 5:687 - 698
   PubMed Web of Science ®Google Scholar
• Hoa NT, Baccigalupi L, Huxham A, Smertenko A, Van PH, Ammendola S, et al. Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders. Appl Environ Microbiol 2000; 66:5241 - 5247
   PubMed Web of Science ®Google Scholar
• Coeuret V, Gueguen M, Vernoux JP. Numbers and strains of lactobacilli in some probiotic products. Int J Food Microbiol 2004; 97:147 - 156
   PubMed Web of Science ®Google Scholar
• Milazzo I, Speciale A, Musumeci R, Fazio D, Blandino G. Identification and antibiotic susceptibility of bacterial isolates from probiotic products available in Italy. New Microbiol 2006; 29:281 - 291
   PubMed Web of Science ®Google Scholar
• Moneret-Vautrin DA, Morisset M, Cordebar V, Codreanu F, Kanny G. Probiotics may be unsafe in infants allergic to cow's milk. Allergy 2006; 61:507 - 508
   PubMed Web of Science ®Google Scholar
• Lee TT, Morisset M, Astier C, Moneret-Vautrin DA, Cordebar V, Beaudouin E, et al. Contamination of probiotic preparations with milk allergens can cause anaphylaxis in children with cow's milk allergy. J Allergy Clin Immunol 2007; 119:746 - 747
   PubMed Web of Science ®Google Scholar
• Momose H, Igarashi M, Era T, Fukuda Y, Yamada M, Ogasa K. Toxicological studies on Bifidobacterium longum BB536. Appl Pharmacol 1979; 17:881 - 887
   Google Scholar
• Ishibashi N, Yamazaki S. Probiotics and safety. Am J Clin Nutr 2001; 73:465 - 470
   PubMed Web of Science ®Google Scholar
• Lara-Villoslada F, Sierra S, Diaz-Ropero MP, Olivares M, Xaus J. Safety assessment of the human milk-isolated probiotic Lactobacillus salivarius CECT5713. J Dairy Sci 2007; 90:3583 - 3589
   PubMed Web of Science ®Google Scholar
• Salminen MK, Tynkkynen S, Rautelin H, Poussa T, Saxelin M, Ristola M, et al. The efficacy and safety of probiotic Lactobacillus rhamnosus GG on prolonged, noninfectious diarrhea in HIV Patients on antiretroviral therapy: a randomized, placebo-controlled, crossover study. HIV Clin Trials 2004; 5:183 - 191
   PubMed Web of Science ®Google Scholar
• Gil L, Siems W, Mazurek B, Gross J, Schroeder P, Voss P, et al. Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radic Res 2006; 40:495 - 505
   PubMed Web of Science ®Google Scholar
• Nielsen K, Duncan J. Animal Brucellosis 1990; Boca Raton, FL CRC Press, Inc
   Google Scholar
• Konikoff MR, Denson LA. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis 2006; 12:524 - 534
   PubMed Web of Science ®Google Scholar
• Patti JM, Bremell T, Krajewska-Pietrasik D, Abdelnour A, Tarkowski A, Rydén C, et al. The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun 1994; 62:152 - 161
   PubMed Web of Science ®Google Scholar
• Beckerman KP, Rogers HW, Corbett JA, Schreiber RD, McDaniel ML, Unanue ER. Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J Immunol 1993; 150:888 - 895
   PubMed Web of Science ®Google Scholar
• Gras V, Bouffandeau B, Montravers PH, Lalau JD. Effect of metformin on survival rate in experimental sepsis. Diabetes Metab 2006; 32:147 - 150
   PubMed Web of Science ®Google Scholar
• Vankerckhoven V, Moreillon P, Piu S, Giddey M, Huys G, Vancanneyt M, Goossens H, et al. Infectivity of Lactobacillus rhamnosus and Lactobacillus paracasei isolates in a rat model of experimental endocarditis. J Med Microbiol 2007; 56:1017 - 1024
   PubMed Web of Science ®Google Scholar
• Moreillon P, Que YA. Infective endocarditis. Lancet 2004; 363:139 - 149
   PubMed Web of Science ®Google Scholar
• Moreillon P, Entenza JM, Francioli P, McDevitt D, Foster TJ, François P, et al. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun 1995; 63:4738 - 4743
   PubMed Web of Science ®Google Scholar
• Cohen MD. Bacterial host resistance models in the evaluation of immunotoxicity. Methods 2007; 41:20 - 30
   PubMed Web of Science ®Google Scholar
• Vessie EL, Hirsch GM, Lee TD. Aortic allograft vasculopathy is mediated by CD8(+) T cells in Cyclosporin A immunosuppressed mice. Transpl Immunol 2005; 15:35 - 44
   PubMed Web of Science ®Google Scholar
• Toxicological Principles for the Safety Assessment of Food Ingredients. Chapter IC.C.9.a: Guideline for Reproduction Studies 2007; 2009 http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredientsandPackaging/Redbook/default.htm
   Google Scholar
• International Conference On Harmonisation Of Technical Requirements For Registration Of Pharmaceuticals For Human Use. Detection Of Toxicity To Reproduction For Medicinal Products & Toxicity To Male Fertility. Harmonised Tripartite Guideline S5(R2) 2005; 2009 http://www.ich.org/LOB/media/MEDIA498.pdf
   Google Scholar
• Claud EC, Walker WA. Bacterial colonization, probiotics and necrotizing enterocolitis. J Clin Gastroenterol 2008; 42:46 - 52
   PubMed Web of Science ®Google Scholar
• Walker WA. Mechanisms of action of probiotics. Clin Infect Dis 2008; 46:87 - 91
   PubMed Web of Science ®Google Scholar
• Patterson JK, Lei XG, Miller DD. The pig as an experimental model for elucidating the mechanisms governing dietary influence on mineral absorption. Exp Biol Med 2008; 233:651 - 654
   PubMed Web of Science ®Google Scholar
• Garthoff LH, Henderson GR, Sager AO, Sobotka TJ, O'Dell R, Thorpe CW, et al. The Autosow raised miniature swine as a model for assessing the effects of dietary soy trypsin inhibitor. Food Chem Toxicol 2002; 40:487 - 500
   PubMed Web of Science ®Google Scholar
• Pang X, Hua X, Yang Q, Ding D, Che C, Cui L, et al. Inter-species transplantation of gut microbiota from human to pigs. Isme J 2007; 1:156 - 162
   PubMed Web of Science ®Google Scholar
• Solano-Aguilar G, Dawson H, Restrepo M, Andrews K, Vinyard B, Urban JF Jr. Detection of Bifidobacterium animalis subsp. lactis (Bb12) in the intestine after feeding of sows and their piglets. Appl Environ Microbiol 2008; 74:6338 - 6347
   PubMed Web of Science ®Google Scholar
• Zhang W, Azevedo MS, Wen K, Gonzalez A, Saif LJ, Li G, et al. Probiotic Lactobacillus acidophilus enhances the immunogenicity of an oral rotavirus vaccine in gnotobiotic pigs. Vaccine 2008; 26:3655 - 3661
   PubMed Web of Science ®Google Scholar
• Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008; 455:1109 - 1113
   PubMed Web of Science ®Google Scholar
• Collado MC, Grzeskowiak L, Salminen S. Probiotic strains and their combination inhibit in vitro adhesion of pathogens to pig intestinal mucosa. Curr Microbiol 2007; 55:260 - 265
   PubMed Web of Science ®Google Scholar
• Solano-Aguilar G, Shea-Donohue T, Madden K, Dawson H, Ledbetter T, Urban JF Jr. Gasbarre LC. The effect of human derived probiotic bacteria on the intestinal function of pigs. AAVP Symposium: New approaches in the study of animal parasites. Vet Parasitol 2004; 125:147 - 161
   PubMed Web of Science ®Google Scholar
• Siggers RH, Siggers J, Boye M, Thymann T, Mølbak L, Leser T, et al. Early administration of probiotics alters bacterial colonization and limits diet-induced gut dysfunction and severity of necrotizing enterocolitis in preterm pigs. J Nutr 2008; 138:1437 - 1444
   PubMed Web of Science ®Google Scholar
• Harding SV, Fraser KG, Wykes LJ. Probiotics stimulate liver and plasma protein synthesis in piglets with dextran sulfate-induced colitis and macronutrient restriction. J Nutr 2008; 138:2129 - 2135
   PubMed Web of Science ®Google Scholar
• Piriou-Guzylack L, Salmon H. Membrane markers of the immune cells in swine: an update. Vet Res 2008; 39:54
   PubMed Web of Science ®Google Scholar
• Porcine Immunology and Nutrition (PIN) database 2009 http://www.ars.usda.gov/Services/docs.htm?docid=6065
   Google Scholar
• Chowdhury SR, King DE, Willing BP, Band MR, Beever JE, Lane AB, et al. Transcriptome profiling of the small intestinal epithelium in germfree versus conventional piglets. BMC Genomics 2007; 8:215
   Google Scholar
• Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008; 6:280
   PubMed Web of Science ®Google Scholar
• Dowd SE, Sun Y, Wolcott RD, Domingo A, Carroll JA. Bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP) for microbiome studies: bacterial diversity in the ileum of newly weaned Salmonella-infected pigs. Foodborne Pathog Dis 2008; 5:459 - 472
   PubMed Web of Science ®Google Scholar
• Von Wright A. Regulating the safety of probiotics—the European approach. Curr Pharm Des 2005; 11:17 - 23
   PubMed Web of Science ®Google Scholar
• Wassenaar TM, Klein G. Safety aspects and implications of regulation of probiotic bacteria in food and food supplements. J Food Prot 2008; 71:1734 - 1741
   PubMed Web of Science ®Google Scholar
• Opinion of the Scientific Committee on Animal Nutrition on the criteria for assessing the safety of micro-organisms resistant to antibiotics of human clinical and veterinary importance 2002; 2009 http://ec.europa.eu/food/fs/sc/scan/out108_en.pdf
   Google Scholar
• Introduction of a Qualified Presumption of Safety (QPS) approach for assessment of selected microorganisms referred to EFSA—Opinion of the Scientific Committee 2007 2009 http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1178667590178.htm
   Google Scholar
• On a generic approach to the safety assessment of micro-organisms used in feed/food and feed/food production 2003; 2009 http://ec.europa.eu/food/fs/sc/scf/out178_en.pdf
   Google Scholar
• Probiotics 2009; 2009 http://www.hc-sc.gc.ca/dhp-mps/prodnatur/applications/licen-prod/monograph/mono_probioti-eng.php
   Google Scholar
• Guidance Document—The Use of Probiotic Microorganisms in Food 2009; 2009 http://www.hc-sc.gc.ca/fn-an/legislation/guide-ld/probiotics_guidance-orientation_probiotiques-eng.php
   Google Scholar
• Sanders M. How do we know when something called ”probiotic” is really a probiotic? A guideline for consumers and healthcare professionals. Functional Food Rev 2009; 1:3 - 12
   Google Scholar
• Immunomodulation by probiotics: efficacy and safety evaluation 2005; 2009 http://www.rivm.nl/bibliotheek/rapporten/340320003.html
   Google Scholar
• Probiotics Task Force 2009; 2009 http://www.ilsi.org/Europe/Pages/TF_Probiotics.aspx
   Google Scholar
• Agency response letter: GRAS Notice No. GRN 000231 2008; 2009 http://www.fda.gov/Food/FoodIngredientsPackaging/GenerallyRecognizedasSafeGRAS/GRASListings/ucm153907.htm
   Google Scholar
• Rayes N, Hansen S, Seehofer D, Müller AR, Serke S, Bengmark S, et al. Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition 2002; 18:609 - 615
   PubMed Web of Science ®Google Scholar
• Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation—a randomized, double-blind trial. Am J Transplant 2005; 5:125 - 130
   PubMed Web of Science ®Google Scholar
• Kanazawa H, Nagino M, Kamiya S, Komatsu S, Mayumi T, Takagi K, et al. Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg 2005; 390:104 - 113
   PubMed Web of Science ®Google Scholar
• Rayes N, Seehofer D, Theruvath T, Mogl M, Langrehr JM, Nüssler NC, et al. Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial. Ann Surg 2007; 246:36 - 41
   PubMed Web of Science ®Google Scholar
• Nomura T, Tsuchiya Y, Nashimoto A, Yabusaki H, Takii Y, Nakagawa S, et al. Probiotics reduce infectious complications after pancreaticoduodenectomy. Hepatogastroenterology 2007; 54:661 - 663
   PubMed Web of Science ®Google Scholar